| 
            Illinois became the first state to hop on the bandwagon for 
            President Bush's New Freedom Commission's plan to subject all 
            American school children to mental health screening. In 2003, 
            Illinois lawmakers passed the $10 million Illinois Children's Mental 
            Health Act, creating a Children's Mental Health Partnership, which 
            many expect to become a model for other states. The final report 
            by the Illinois Children's Mental Health Task Force was released in 
            April 2003, and it is filled with intrusive and expensive 
            recommendations. The Illinois Children's Mental Health Partnership 
            had hearings in various locations across the state in 2004 to gather 
            public feedback on the plan. 
            While its proposals seem harmless enough at first glance, 
            comments from parents during the hearings raised many valid 
            concerns. The state, critics said, no longer assumes that Illinois 
            children are mentally healthy; it presumes all children need mental 
            health screening. 
            The task force report calls for a comprehensive, coordinated 
            children's mental health system comprised of prevention, early 
            intervention and treatment for children from birth to age 18; a 
            statewide data-reporting system to track information on each person; 
            and social-emotional development screens with all mandated school 
            exams (kindergarten, fourth grade and ninth grade). 
            The task force wants to start early, beginning prenatally and at 
            birth, and continue throughout adolescence, including efforts to 
            support adolescents in making the transition to young adulthood. 
            Karen Hayes, associate director of Concerned Women for 
            America-Illinois, published an opinion piece in the Illinois Leader 
            on July 23, 2004, and had a great idea. She said maybe the 
            legislators should be mentally evaluated. 
            Concerned parent Joseph Volpendesta feels the same way. In a June 
            13 letter to the editor of the Illinois Leader, he said: "Mental 
            health screening might be much more usefully employed on these 
            people who come up with these brainstorms. It is obvious that they 
            have far too much time on their hands and too little regard for 
            those of us who are paying the bills. What is needed, and at the 
            earliest opportunity, is a bill to rescind this piece of legislative 
            claptrap. ... There is no doubt in my mind where the mental health 
            screening is most needed, and it ain't the kids." 
            
            TeenScreen customer recruitment scheme 
            
            At the center of the controversy is program called TeenScreen, 
            designed by pharmaceutical-backed officials at Columbia University. 
            TeenScreen is supposedly a suicide-prevention program and is 
            recommended by the New Freedom Commission, even though a recent U.S. 
            Preventive Services Task Force study found "no evidence that 
            screening for suicide risk reduces suicide attempts or mortality." 
            Columbia claims the TeenScreen survey can assess the symptoms of 
            eight disorders associated with the risk of suicide or mental 
            illness. On March 2, 2004, the program's executive director, Laurie 
            Flynn, testified at a congressional hearing and said that in the 
            screening process, "Youth complete a 10-minute self-administered 
            questionnaire that screens for social phobia, panic disorder, 
            generalized anxiety disorder, major depression, alcohol and drug 
            abuse, and suicidality." 
            In May 2004, Illinois lawmakers passed a resolution approving the 
            implementation of TeenScreen in public schools. The resolution said 
            in part (1) that the Columbia TeenScreen program has been proven 
            successful, offers technical assistance for implementation of a 
            screening program and provides all the components for such a program 
            at no charge at this time; (2) that we recognize that mental illness 
            and suicide among young people are public health crisis in this 
            state and that all residents of Illinois should make the 
            identification of mental disorders and the prevention of suicide 
            among the young people a public health priority; (3) that every 
            young person should be screened ... to identify mental illness and 
            prevent suicide; and (4) that such a screening and identification 
            process should employ sound, evidence-based tools. 
            The problem is that TeenScreen is not an evidence-based tool. The 
            program had already been in place for six years in Tulsa, Okla., 
            when the suicide rate rose drastically, causing Michael Brose, the 
            leader of a mental health partnership organization there, to say, 
            ''To the best of my knowledge, this is the highest number of youth 
            suicides we've ever had during the school year -- a number we find 
            very frightening." 
            TeenScreen is an invention of the pharmaceutical industry and is 
            nothing more than a customer recruitment scheme to help generate 
            high-volume sales of costly psychiatric drugs. By infiltrating the 
            nation's public school system, it will generate millions of new 
            prescription drug customers. 
            "More screened kids means more money for psychiatrists and the 
            pharmaceutical industry," said Vera Hassner Sharav, president of the 
            Alliance for Human Research Protection, a patient advocacy group, to 
            the Chicago Tribune on June 5. 
            "It is important to understand that powerful interests, namely 
            federal bureaucrats and pharmaceutical lobbies, are behind the push 
            for mental health screening in schools. ... The pharmaceutical 
            industry is eager to sell psychotropic drugs to millions of new 
            customers in American schools," said Rep Ron Paul, R-Texas, who 
            happens to be a physician. 
            TeenScreen made its Illinois debut last fall at the Brimfield 
            High School in the Peoria area, and reports indicate that several 
            more Illinois schools will be implementing the program next year, 
            according to investigative reporter Rhonda Robinson. 
            
            TMAP and IMAP 
            
            Parent Dennis McLouth of Roseville wrote in a letter to the 
            editor of the Illinois Leader on June 13: "Do the big drug companies 
            have so much power? Why else would this be happening? It looks like 
            a way to make more young people dependent on prescription drugs 
            earlier in life, when all they really need is to deal with growing 
            up, just like we all did before there was a drug for every ailment 
            and new ailment to justify even more new drugs."  
            My answer to Dennis is: Yes, the drug companies are that 
            powerful, and it gets worse. The New Freedom Commission recommends a 
            drug treatment program called the Texas Medical Algorithm Project, 
            which specifically requires doctors to prescribe the newer 
            generation of psychiatric drugs to children, including the 
            antidepressants known as the selective serotonin reuptake 
            inhibitors, or SSRIs, which can lead children to commit suicide or 
            other violent acts. 
            According to the American Hospital Formulary Service Drug 
            Information 2005, the "FDA now states that it has determined that 
            antidepressants increase the risk of suicidal thinking and behavior 
            in children and adolescents with major depressive and other 
            psychiatric disorders." 
            Dr. Ann Blake Tracy is the executive director of the 
            International Coalition for Drug Awareness and the author of 
            "Prozac, Panacea or Pandora: Our Seratonin Nightmare." She testified 
            at a February 2004 FDA hearing on the adverse effects of SSRIs and 
            said: "Research on serotonin has been clear from the very beginning 
            that the most damaging thing that could be done to the serotonin 
            system would be to impair one's ability to metabolize serotonin. Yet 
            that is exactly how SSRI antidepressants exert their effects." 
            Tracy said that for decades research has shown that impairing 
            serotonin metabolism will produce numerous health problems including 
            "pains around the heart, difficulty breathing, tension and anxiety 
            which appear from out of nowhere, depression, suicide -- especially 
            very violent suicide, hostility, violent crime, arson, substance 
            abuse, psychosis, mania," and the list goes on and on. 
            "How anyone ever thought it would be 'therapeutic' to chemically 
            induce these reactions is beyond me," she said. 
            In one study reviewed by the FDA panel, in a pool of 931 
            depressed patients taking SSRIs listed on the Texas Medical 
            Algorithm Project, versus 811 depressed patients taking a placebo, 
            there were 52 suicidal acts by people on the SSRIs versus 18 on 
            placebo. 
            The drug companies withheld the studies that showed the drugs 
            were basically ineffective on kids and that they were in fact 
            dangerous. Most of the studies that have surfaced over the past 
            couple years were unearthed during the discovery process of recent 
            lawsuits against drug companies. 
            Pediatrician Dr Karen Effren questions whether the Texas Medical 
            Algorithm Project list should be used at all. "If data is withheld 
            about the dangers or lack of effectiveness of the new psychiatric 
            drugs, why should physicians believe and carry out the 
            recommendations of the New Freedom Commission for treatment, such as 
            the Texas Medication Algorithm Project, that uses those drugs as 
            paid for the state incentive grants?" 
            These same sentiments had already been expressed in January 1999 
            by Peter Weiden, M.D., who was one of the participants on the 
            original panel that approved drugs to be on the Texas Medical 
            Algorithm Project list, when he openly criticized the process in the 
            Journal of Practice in Psychiatry and Behavioural Health. 
            Weiden pointed out the fact that drug company money was involved 
            in the approval of the list. "Another problem is potential bias from 
            funding sources," he said. "The 1996 guidelines were funded by 
            Janssen (makers of Risperidone [Risperdal]), and most of the 
            guidelines' authors have received support from the pharmaceutical 
            industry. This potential conflict of interest may create credibility 
            problems, especially concerning any recommendations supporting the 
            use of atypical antipsychotics." 
            Other drug companies besides Janssen were involved in the 
            creation of the list. And drug company money was also used to grease 
            the palms of politicians who would ultimately have to approve the 
            Texas Medical Algorithm Project scheme. 
            For instance, Eli Lilly helped fund the guidelines and also has 
            well-known ties to both Bush administrations. After Bush Sr. left 
            the CIA in 1977, he became a member of Lilly's board of directors. 
            When he left the company to become Reagan's vice president in 1980, 
            he forgot to mention that he still owned stock in the company at the 
            same time that he was lobbying for tax breaks for Lilly, even though 
            it manufactured drugs in Puerto Rico. 
            Bush Jr. made Eli Lilly CEO Sidney Taurel a member of the 
            Homeland Security Department, and his former director of the Office 
            of Management and Budget, Mitch Daniels, was also a former senior 
            vice president of Lilly. 
            In the 2000 election the company contributed over $1.5 million to 
            political candidates, with over 80 percent going to Bush and the 
            Republican Party. 
            According to the Center for Responsive Politics, in his two bids 
            for the presidency, Bush has been the No. 1 recipient from either 
            party for campaign donations from the pharmaceutical industry. The 
            same Robert Wood Johnson IV who has ties to the foundation that 
            funded the Texas Medical Algorithm Project is also heir to the 
            Johnson & Johnson fortune, and he raised over $100,000 for Bush's 
            2000 campaign and over $200,000 for the 2004 campaign. 
            The Robert Wood Johnson Foundation also helped fund the Illinois 
            Children's Mental Health Task Force, which produced the report that 
            the Illinois' Children's Mental Health Act of 2003 is based on, 
            according to investigative reporter Rhonda Robinson. 
            The Illinois version of the Texas Medical Algorithm Project list 
            is the IMAP, and it is already in place in 23 Illinois counties, 
            Robinson reports. 
            
            Tax-dollar-funded drug pushers 
            
            Let there be no mistake about it: Kids sent to shrinks will end 
            up on drugs. In 2002, a survey of recently trained child 
            psychiatrists found that only one in 10 children in their practices 
            did not receive a medication. ("A survey of early-career child and 
            adolescent psychiatrists," D.E. Stubbe and W.J. Thomas, Journal of 
            the American Academy of Child & Adolescent Psychiatry, 2002) 
            
            [to top of second column in this article] 
            
            
               | 
            
             
             A 2004 review by Medco Health Solutions of prescription data for 
            300,000 children ages 19 and younger concluded that for the first 
            time in history, spending for medications for childhood behavior 
            problems eclipsed expenditure for any other drug category, including 
            antibiotics. 
            The final draft of the Illinois plan issued this month wants to 
            promote effective use of Medicaid's early periodic screening, 
            diagnosis and treatment benefit in Illinois to support voluntary 
            screening of children from birth to 18 years and wants to "clarify 
            for providers the diagnoses that create eligibility for children to 
            obtain Medicaid services." 
            I wonder how many people are curious as to what might be in store 
            for the kids they want to screen at birth. To answer that question, 
            an investigation of the drugs being prescribed to Illinois kids on 
            Medicaid might be helpful. 
            On April 25, the headlines of the Ohio Columbus Dispatch read: 
            "Drugged into submission, even babies getting treated as mentally 
            ill." Doctors prescribed sedatives and powerful, mood-altering 
            medications for nearly 700 Ohio babies and toddlers on Medicaid last 
            summer, according to a Dispatch review of records. 
            An investigation by the Dispatch revealed that at least 696 Ohio 
            children who were newborn to 3 years old received mental health 
            drugs paid for by Medicaid in July 2004. Hydroxyzine was prescribed 
            most often, with about three-quarters of the kids on it. The drug, a 
            long-acting antihistamine, relieves itching caused by allergies, 
            controls vomiting and reduces anxiety, but it is given to young 
            children most often for its sedative effects. 
            In addition, more than 90 kids were on another antihistamine, 48 
            were taking antianxiety medication and 28 were prescribed 
            antidepressants, including the SSRIs Paxil, Prozac and Zoloft. 
            Twenty-seven received Valium, and 18 were on antipsychotics. 
            This revelation set off alarms in Ohio. "It's troubling," said 
            John Saros, executive director of Franklin County Children Services. 
            "How do doctors even determine that a 2-year-old is anxious? There's 
            a reason they call it the 'terrible twos.'" 
            In total, nearly 40,000 Ohio children on Medicaid were taking 
            drugs for anxiety, depression, delusions, hyperactivity and violent 
            behavior when the investigation was conducted in July 2004, 
            according to the Dispatch. 
            Illinois' new program keeps stressing that treatment should be 
            funded by Medicaid. That means drugs, folks. Over-drugging kids on 
            Medicaid in Ohio is not an isolated practice. It's happening all 
            over the country. 
            On Jan. 15, the Miami Herald reported that nearly 1,900 children 
            under the care of Florida's child welfare system are taking 
            antidepressant drugs, despite a strong federal warning that such 
            medications are linked to an increased risk of suicidal thinking. 
            Similar findings held true in Tennessee for kids covered by the 
            state insurance program. A study conducted in 2004 by Dr. William 
            Cooper, an associate professor of pediatrics at Vanderbilt 
            University in Nashville, determined that the use of antipsychotic 
            drugs among low-income children in Tennessee had nearly doubled 
            between 1996 and 2001. 
            Cooper's report, published in the Aug. 3, 2004, issue of the 
            Archives of Pediatric Adolescent Medicine, found that young people 
            who are not psychotic are being prescribed antipsychotic drugs for 
            which there was no data on safety or effectiveness. 
            The study revealed that the proportion of TennCare children who 
            were prescribed antipsychotics nearly doubled in six years. The most 
            dramatic increases were among those aged 13 to 18 (116 percent) and 
            those 6 to 12 (93 percent). Cooper also found that use among 
            preschool children had increased by 61 percent. 
            If the Illinois governor signs the new law on June 30, in 
            addition to children, all pregnant women will be screened for 
            depression during pregnancy and for up to 1 year following a baby's 
            birth. The treatment for depression mandated by the IMAP drug list 
            will be the SSRI antidepressants, even though new studies indicate 
            that SSRIs taken by pregnant women can have serious adverse affects 
            on the unborn fetus. 
            "Newborn babies could be at risk of suffering withdrawal symptoms 
            if their mothers are prescribed antidepressants during pregnancy," 
            according to a Reuters article on Feb. 4. 
            Professor Emilio Sanz of the University of La Laguna in Tenerife, 
            Spain, conducted a study that showed that SSRIs can cause 
            convulsions, irritability, abnormal crying and tremors in newborn 
            babies. 
            For the study, Professor Sanz and his team of researchers 
            searched the World Health Organization database from 72 countries 
            for the adverse drug reactions associated with the use of SSRIs, 
            Reuters reported. 
            Karen Hayes thinks the whole plan stinks. "Proposing that state 
            government set mental health competency standards for all Illinois 
            pregnant women and children to age 18 stuns human sensibilities," 
            Hayes wrote. "This proposal calls for collection of mental health 
            data of women and children, together with bureaucratic linkage of 
            this information." 
            She's got that right, because according to the plan, the state of 
            Illinois will improve accountability, data tracking and reporting 
            for children's mental health in relevant programs and services and 
            will (1) institute contract and monitoring changes to increase the 
            accountability of current children's mental health providers; (2) 
            develop a statewide data-tracking and reporting system to collect 
            information on key indicators of children's social and emotional 
            development and mental health status; (3) develop policies and 
            protocols for the sharing of databases among relevant state and 
            local agencies; and (4) explore the development of uniform reporting 
            forms and tests in select programs for the tracking, reporting and 
            planning of services. 
            
            Follow the tax dollars 
            
            The task force says it wants to maximize the use of Medicaid and 
            KidCare by streamlining enrollment, capitalizing on federal 
            reimbursement and implementing key cost-saving strategies, with 
            savings deposited into a Children's Mental Health Fund. 
            It wants to (1) improve Medicaid reimbursement for prevention, 
            early intervention and treatment services; (2) recognize diagnoses 
            for young children described in DC:0-3 and pay for mental health 
            services for children with any of these diagnoses; (3) clarify for 
            providers the diagnoses that create eligibility for children to 
            obtain Medicaid services. 
            Translation: That means to make sure "treatment" (aka pills) will 
            be paid for, people will be trained to diagnose kids only with 
            disorders that are covered by Medicaid. 
            The task force plan leaves no funding stone unturned. It even 
            wants to "change the Illinois KidCare and Medicaid eligibility 
            procedures to allow for self-attestation of a family's financial 
            circumstances in lieu of current financial documentation 
            requirements," which means all I have to do is swear I'm poor to 
            qualify for Medicaid in Illinois. 
            Drug companies smell the tax dollars, and they want these 
            Illinois kids. Over 2 million children were enrolled in Illinois 
            public schools, pre-K through 12th grade, during the 2001-02 school 
            year. Over 960,000 children were enrolled in Medicaid and KidCare in 
            2002, and a recent study in Chicago claimed that nearly 50 percent 
            of inner-city adolescents demonstrated signs and symptoms of 
            depression. 
            So let's do the math and see how much the psychiatric-industrial 
            complex stands to gain. The plans says to "ensure that all children 
            enrolled in Medicaid receive periodic developmental screens ... as 
            mandated under the early and periodic screening diagnostic treatment 
            program." 
            Let's say the initial diagnostic visit to the shrink costs $150. 
            What's 150 times 960,000? 
            The report said 50 percent of Chicago inner-city kids were 
            depressed, so we'll use that percentage for the kids on Medicaid. 
            Half of 960,000 means 480,000 kids are set to be prescribed 
            antipsychotic drugs right from the get-go. 
            Offhand I don't know how much all the different drugs cost, but I 
            have personal knowledge that the cost of Risperdal in 2001 was close 
            to $500 for a 30-day supply. 
            In 2001, The Miami Herald published a series of stories about the 
            common use of Risperdal among children in state care. Child welfare 
            advocates said the drug routinely was being used by foster care 
            providers as a ''chemical restraint'' on children whose unruly 
            behavior was a frustration to caretakers. 
            Risperdal is on the IMAP list as the leading drug used to combat 
            schizophrenia and other types of psychotic disorders and earns 
            Janssen about $2.1 billion in annual sales. The drug is prescribed 
            to more than 10 million people worldwide, according to the Herald. 
            I suspect a heavy-duty calculator will be needed to calculate 
            dollar amounts for the potential cost of Risperdal prescriptions to 
            the taxpayers of Illinois. 
            
            Taxpayers may foot entire bill 
            
            No doubt about it, the promoters of this scheme are looking to 
            grab tax dollars from every public trough known to man. The plan 
            lists a host of public funding sources to be examined and includes 
            Medicaid and the State Children's Health Insurance Program, the 
            Social Services Block Grant, Temporary Assistance for Needy 
            Families, the Child Care and Development Fund, the Title V Maternal 
            and Child Health Services Block Grant, Parts B (special education) 
            and C (early intervention) of the Individuals with Disabilities 
            Education Act, Juvenile Justice, and state funding sources. 
            In her opinion piece, Karen Hayes questioned the feasibility of 
            such a large publicly funded program: "Our government bureaucracies 
            continue to struggle with the job of tending to the social needs of 
            needy Illinois families, and ... trying to educate our children in 
            basic academics. How is it that these same bureaucracies can now be 
            asked to take on the additional role of being the mental health 
            evaluator and caretaker of all pregnant women and children in 
            Illinois? 
            "At a time when budget concerns are on the front pages of most 
            Illinois newspapers, we are being asked to give input to one of the 
            costliest expansions of government and bureaucracy we have seen in 
            recent years. 
            "In summary, it is neither beneficial to children, nor to 
            taxpayers, to ask government bureaucracies to set competency 
            standards for mental health. With some amount of lightheartedness, 
            may I propose that the mental health of the perpetrators of this 
            concept be evaluated?" 
            Another parent agrees with her. "The Illinois Legislature ought 
            to have their own heads subjected to adolescent mental health 
            screening for even considering passing such legislation," said Jack 
            Kime, in a June 13 letter to the Illinois Leader. "If there is 
            anything more dangerous than having the government put such a 
            program in place, I don't know what it might be," he said. 
            [Evelyn Pringle] 
            Evelyn Pringle is a 
            columnist for Independent Media TV and an investigative journalist 
            focused on exposing government corruption. 
            
            Click here to respond to the editor about this 
            article.  |